Buy Algeness Agarose Subdermal Filler 4 VL
Algeness Agarose Subdermal Filler is a type of volumizing filler made of Agarose, a natural derivative of seaweed (red algae) – the most biocompatible material available today, and is the basic material used for biocompatibility testing throughout the medical and scientific community.
Algeness Agarose Subdermal Filler VL For the first time in the aesthetic medicine history is 100% natural, biocompatible, and biodegradable injectable implant is available on the market fulfilling the expectations and requirements of the most demanding practitioners.
What is the composition of Algeness filler?
Algeness Agarose Subdermal Filler is a biomaterial consists of a purified agarose gel (polysaccharide), derived from a sophisticated manufacturing process. contains 2.5% Agarose (High density), 0.5% non crossed-linked HA, 97% sterile saline.
Algeness is used for the following indications:
- Medium to deep volumetric filling
- Cheeks, jawline and chin
- Nasolabial folds
- Malar-zygomatic arch
- Use linear and retrograde techniques for application with an injection depth up to the deep soft tissue layers of skin.
How Long Does Algeness Filler last?
Algeness Agarose Subdermal Filler VL last for 4 months to 12 months
Algeness comes in three concentrations, with effects that last from 4 months to 12 months or more depending on the individual’s lifestyle., equal to or better than the industry’s current crop of Hyaluronic dermal fillers according to the manufacturer.
Follow up treatments should be carried out after 7-10 days.
ALGENESS: THE NEW BENCHMARK FOR SUBDERMAL FILLERS
The fulfillment of the patients’ requirements is a challenge when the results must be achieved immediately and safely with an all-natural look and this can be done with the confidence of a controlled injection technique which we call “Master Your ResultsTM” The right filler is very important, when the physician is requested to deliver immediate results safely, confidently and with precision.
Reviews
There are no reviews yet.